PPARG and arthritic joint disease: Notably, this anti-inflammatory effect of PPARγ ligands extends to the inhibition of IL-1β-induced expression of MMP-1 and MMP-13 in rabbit chondrocytes [2,17,18], and administration of these compounds blunts the development of joint disease in animal models of arthritis [18,19].